Haldol

Haldol is the brand name for the generic drug haloperidol, a typical antipsychotic of the butyrophenone class. It is supplied in oral dosage form, with strength and specific formulation varying by market; the product is authorized for prescription use in the European Union. Haloperidol works primarily as a dopamine D2 receptor antagonist to help manage certain psychiatric conditions and associated symptoms under medical supervision through careful dosing.

Haloperidol is prescribed for several psychiatric disorders where dopamine dysregulation is implicated.

- Schizophrenia, including maintenance therapy for chronic illness. - Acute psychotic episodes, such as those related to substance intoxication or withdrawal. - Manic episodes associated with bipolar disorder when rapid control of agitation is needed. - Tourette syndrome, particularly for reducing motor and vocal tics. - Severe agitation or aggression in hospital settings when other measures are insufficient. - Adjunctive treatment for severe anxiety disorders when standard therapies have failed.

Like other typical antipsychotics, haloperidol may cause a range of neurological and non‑neurological effects.

Common: - Drowsiness or sedation. - Dry mouth and increased thirst. - Constipation or reduced gastrointestinal motility. - Extrapyramidal symptoms such as mild tremor, rigidity, or akathisia. - Blurred vision or difficulty focusing.

Serious: - Tardive dyskinesia, characterized by involuntary, repetitive movements. - Neuroleptic malignant syndrome, a life‑threatening reaction with fever and muscle rigidity. - Severe hypotension or cardiac arrhythmias. - Elevated prolactin levels leading to galactorrhea or menstrual disturbances. - Seizures, particularly in patients with a history of epilepsy. - Persistent or worsening extrapyramidal symptoms requiring medical intervention.

Clinicians should evaluate patient history and monitor for specific risks before and during haloperidol therapy.

- History of cardiovascular disease, as haloperidol can affect heart rhythm. - Pre‑existing movement disorders, which may be worsened by extrapyramidal side effects. - Liver or kidney impairment, which may alter drug clearance. - Pregnancy or breastfeeding status, because safety data are limited. - Elderly patients, especially those with dementia, who have higher sensitivity to sedation and falls. - Concomitant use of other dopamine‑blocking agents, increasing risk of severe side effects.

Haloperidol interacts with several medication classes; awareness helps prevent adverse events.

Avoid: - Other antipsychotics or dopamine antagonists, which can amplify extrapyramidal effects. - Drugs that prolong the QT interval, such as certain antiarrhythmics or macrolide antibiotics. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that raise haloperidol plasma levels.

Use with caution: - CNS depressants, including benzodiazepines and opioids, due to additive sedation. - Anticholinergic agents, which may mask early signs of extrapyramidal symptoms. - Lithium, because combined use can increase neurotoxicity risk. - Antihypertensive medications, as haloperidol may cause orthostatic hypotension.